A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

She blamed irritable bowel syndrome, constipation and even a tight bra. Looking back, she had some classic symptoms of colon ...

Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...

Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 years before they become malignant. This innovative ...

Doctors at Bhopal's Hamidia Hospital performed a historic surgery, creating a new stomach from the small intestine for a ...

The NHS doesn’t offer bowel screening until we’re 50. Yet with cancer rates rising, it may be worth forking out for a private ...

In most cases, the cause is something other than cancer. Learn more about bowel cancer. Seek professional guidance if any change in bowel movements has persisted for more than a few days.

Colorectal cancer can seem a lot like some common gastrointestinal (GI) disorders, including hemorrhoids, irritable bowel syndrome ... starts out as a polyp, or small growth, in the intestine.

New Delhi: The government may propose duty cuts in the Union budget for medicines imported to treat cancer and rare diseases, offering relief for patients burdened with the increasing cost of such ...

Bowel cancer is the second-biggest cancer killer in the UK, and recent research suggests the risk of developing it is rising. Last year bowel cancer rates were reported to be rising more sharply ...

explained that the patient suffered from a condition called delayed vaginal vault dehiscence with small bowel prolapse and obstruction, which is extremely rare, affecting fewer than 0.1% of women ...

Although the small intestine makes up the largest part of the gastrointestinal (GI) tract, small intestine cancers are rare in ... 2025-cancer-facts-figures.html Chamberlain RS, Krishnaraj M, Shah SA.